Investigational Site Number :3800003

Catanzaro 88100

0 studies enrolling now · 2 studies all time

What they study most

Neurodermatitis, Type 2 Diabetes Mellitus

Studies at this site

• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early